Identification of EGFR expression status association with metastatic lymph node density (ND) by expression microarray analysis of advanced gastric cancer (Q35032328)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Identification of EGFR expression status association with metastatic lymph node density (ND) by expression microarray analysis of advanced gastric cancer	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Identification of EGFR expression status association with metastatic lymph node density (ND) by expression microarray analysis of advanced gastric cancer (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Keishi Yamashita

3

object named as

Keishi Yamashita

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

author name string

Akira Ema

1

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Mina Waraya

2

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Kenichi Kokubo

4

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Hirosuke Kobayashi

5

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Keika Hoshi

6

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Yoshiko Shinkai

7

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Hiroshi Kawamata

8

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Kazunori Nakamura

9

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Hiroshi Nishimiya

10

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Natsuya Katada

11

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Masahiko Watanabe

12

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

language of work or name

0 references

publication date

26 August 2014

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Cancer Medicine

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

90-100

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Epigenetic silencing of HOPX promotes cancer progression in colorectal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4312122

8 July 2018

Receptor for advanced glycation end products (RAGE) functions as receptor for specific sulfated glycosaminoglycans, and anti-RAGE antibody or sulfated glycosaminoglycans delivered in vivo inhibit pulmonary metastasis of tumor cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4312122

8 July 2018

NKX2-1/TITF1/TTF-1-Induced ROR1 is required to sustain EGFR survival signaling in lung adenocarcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4312122

8 July 2018

A comprehensive survey of genomic alterations in gastric cancer reveals systematic patterns of molecular exclusivity and co-occurrence among distinct therapeutic targets

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4312122

8 July 2018

Antitumor effect of cetuximab in combination with S-1 in EGFR-amplified gastric cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4312122

8 July 2018

Phase II trial of modified FOLFOX6 and erlotinib in patients with metastatic or advanced adenocarcinoma of the oesophagus and gastro-oesophageal junction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4312122

8 July 2018

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4312122

8 July 2018

Examination of copy number variations of CHST9 in multiple types of hematologic malignancies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4312122

8 July 2018

GP369, an FGFR2-IIIb-specific antibody, exhibits potent antitumor activity against human cancers driven by activated FGFR2 signaling

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4312122

8 July 2018

Potential utility of HOP homeobox gene promoter methylation as a marker of tumor aggressiveness in gastric cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4312122

8 July 2018

A census of amplified and overexpressed human cancer genes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4312122

8 July 2018

Increased nucleotide polymorphic changes in the 5'-untranslated region of delta-catenin (CTNND2) gene in prostate cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4312122

8 July 2018

K-ras mutations and benefit from cetuximab in advanced colorectal cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4312122

8 July 2018

EGFR in gastric carcinomas: prognostic significance of protein overexpression and high gene copy number

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4312122

8 July 2018

FGFR2-amplified gastric cancer cell lines require FGFR2 and Erbb3 signaling for growth and survival

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4312122

8 July 2018

HOP/OB1/NECC1 promoter DNA is frequently hypermethylated and involved in tumorigenic ability in esophageal squamous cell carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4312122

8 July 2018

Genomic profiling identifies TITF1 as a lineage-specific oncogene amplified in lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4312122

8 July 2018

Capecitabine and oxaliplatin for advanced esophagogastric cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4312122

8 July 2018

Characterizing the cancer genome in lung adenocarcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4312122

8 July 2018

Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4312122

8 July 2018

Surgical treatment of advanced gastric cancer: Japanese perspective

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4312122

8 July 2018

Homeobox gene HOP has a potential tumor suppressive activity in human lung cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4312122

8 July 2018

N-methyl-D-aspartate receptor type 2B is epigenetically inactivated and exhibits tumor-suppressive activity in human esophageal cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4312122

8 July 2018

Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4312122

8 July 2018

Immunohistochemical detection of K-sam protein in stomach cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4312122

8 July 2018

Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer

1 reference

https://api.crossref.org/works/10.1002%2FCAM4.311

21 January 2018

Lymph node ratio is a critical prognostic predictor in gastric cancer treated with S-1 chemotherapy.

1 reference

https://api.crossref.org/works/10.1002%2FCAM4.311

21 January 2018

Is it time for a new TNM classification in esophageal carcinoma?

1 reference

https://api.crossref.org/works/10.1002%2FCAM4.311

21 January 2018

Stage migration effect on survival in gastric cancer surgery with extended lymphadenectomy: the reappraisal of positive lymph node ratio as a proper N-staging

1 reference

https://api.crossref.org/works/10.1002%2FCAM4.311

21 January 2018

High concordance between HercepTest immunohistochemistry and ERBB2 fluorescence in situ hybridization before and after implementation of American Society of Clinical Oncology/College of American Pathology 2007 guidelines

1 reference

https://api.crossref.org/works/10.1002%2FCAM4.311

21 January 2018

Impact of expression of human epidermal growth factor receptors EGFR and ERBB2 on survival in stage II/III gastric cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCAM4.311

21 January 2018

Predictive factors for the efficacy of cetuximab plus chemotherapy as salvage therapy in metastatic gastric cancer patients.

1 reference

https://api.crossref.org/works/10.1002%2FCAM4.311

21 January 2018

Gene copy number for epidermal growth factor receptor (EGFR) and clinical response to antiEGFR treatment in colorectal cancer: a cohort study

1 reference

https://api.crossref.org/works/10.1002%2FCAM4.311

21 January 2018

Phase II trial of erlotinib in gastroesophageal junction and gastric adenocarcinomas: SWOG 0127.

1 reference

https://api.crossref.org/works/10.1002%2FCAM4.311

21 January 2018

Pharmacologic unmasking of epigenetically silenced tumor suppressor genes in esophageal squamous cell carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FCAM4.311

21 January 2018

Expression profiles of HER2, EGFR, MET and FGFR2 in a large cohort of patients with gastric adenocarcinoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4312122

25 October 2018

Surgical resection of stage IV gastric cancer and prognosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4312122

25 October 2018

Antisense epidermal growth factor receptor delivered by adenoviral vector blocks tumor growth in human gastric cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/25154973

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Semi-quantitative fluorescent PCR analysis identifies PRKAA1 on chromosome 5 as a potential candidate cancer gene of cervical cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/25154973

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lymph node metastasis density and growth pattern as independent prognostic factors in advanced esophageal squamous cell carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/25154973

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The number of metastatic lymph nodes and the ratio between metastatic and examined lymph nodes are independent prognostic factors in esophageal cancer regardless of neoadjuvant chemoradiation or lymphadenectomy extent

1 reference

https://pubmed.ncbi.nlm.nih.gov/25154973

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lymph node metastasis density (ND)-factor association with malignant degree and ND40 as "non-curative factor" in gastric cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/25154973

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical significance of total gastrectomy for proximal gastric cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/25154973

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

delta-Catenin promotes malignant phenotype of non-small cell lung cancer by non-competitive binding to E-cadherin with p120ctn in cytoplasm

1 reference

https://pubmed.ncbi.nlm.nih.gov/25154973

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of a lymph node ratio-based staging system with the 7th AJCC system for gastric cancer: analysis of 18,043 patients from the SEER database

1 reference

https://pubmed.ncbi.nlm.nih.gov/25154973

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metastatic lymph node ratio versus number of metastatic lymph nodes as a prognostic factor in gastric cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/25154973

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Discussion of the applicability of positive lymph node ratio as a proper N-staging for predication the prognosis of gastric cancer after curative surgery plus extended lymphadenectomy

1 reference

https://pubmed.ncbi.nlm.nih.gov/25154973

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Amplification of epidermal growth factor receptor gene and its relationship to survival in human gastric cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/25154973

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1002/CAM4.311

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35032328&oldid=1982670781"